Back to Amundi Amundi

RPRXRPRX
21 quarters

Position history for AmundiAmundi's holdings in ROYALTY PHARMA PLC

Amundi holds 3.7M shares of RPRX (ROYALTY PHARMA PLC), worth $208.8M as of 2026-Q2. The position was increased (+20.6% shares). RPRX represents 0.1% of Amundi's portfolio.

Current Value

$208.8M

Current Shares

3.7M

Total Value Change

+$92.9M

Total Shares Change

+895,599

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.7M
+20.6%
$208.8M0.1%$55.85
36
2026-Q1
Increased
3.1M
+15.3%
$148.2M0.0%$47.57
35
2025-Q4
Increased
2.7M
+29.4%
$103.5M0.0%$38.12
38
2025-Q3
Decreased
2.1M
-26.0%
$74.8M0.0%$34.61
0
2025-Q2
Increased
2.8M
+126.1%
$101.2M0.0%$35.13
48
2025-Q1
Decreased
1.2M
-51.5%
$39.3M0.0%$30.15
0
2024-Q4
Decreased
2.6M
-30.8%
$66.9M0.0%$24.55
0
2024-Q3
Increased
3.7M
+78.8%
$101M0.0%$27.00
46
2024-Q2
Decreased
2.1M
-6.5%
$53.5M0.0%$24.97
0
2024-Q1
Decreased
2.2M
-40.2%
$61.6M0.0%$28.55
0
2023-Q4
Increased
3.7M
+129.1%
$104.6M0.0%$26.21
48
2023-Q3
Increased
1.6M
+17.5%
$44.9M0.0%$25.14
34
2023-Q2
Increased
1.4M
+32.9%
$42.1M0.0%$28.28
37
2023-Q1
Increased
1M
+4.3%
$37.5M0.0%$32.95
30
2022-Q4
Increased
990,276
+19.4%
$33.7M0.0%$35.95
34
2022-Q3
Decreased
829,606
-11.4%
$34.6M0.0%$36.39
0
2022-Q2
Increased
936,566
+212.2%
$40.4M0.0%$37.91
47
2022-Q1
Increased
299,977
+50.2%
$12.2M0.0%$34.97
39
2021-Q4
Decreased
199,723
-85.7%
$8M0.0%$35.60
0
2021-Q3
Decreased
1.4M
-50.7%
$50.4M0.0%$32.15
0
2021-Q2
New
2.8M
-
$115.9M0.1%$36.31
42

Other major holders of RPRX: MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used